Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A by Benjamin J. Samelson-Jones, Benjamin J. Samelson-Jones, Benjamin J. Samelson-Jones, Valder R. Arruda, Valder R. Arruda, Valder R. Arruda

Get full text

Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy by Benjamin J. Samelson-Jones, Valder R. Arruda

Get full text

Emerging therapies for hemophilia: controversies and unanswered questions [version 1; referees: 4 approved] by Valder R. Arruda, Bhavya S. Doshi, Benjamin J. Samelson-Jones

Get full text

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates by Benjamin J. Samelson-Jones, Jonathan D. Finn, Patricia Favaro, J. Fraser Wright, Valder R. Arruda

Get full text

Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs. by Mary Beth Callan, Mark E Haskins, Ping Wang, Shangzhen Zhou, Katherine A High, Valder R Arruda

Get full text

AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life by Bhavya S. Doshi, Benjamin J. Samelson-Jones, Timothy C. Nichols, Elizabeth P. Merricks, Joshua L. Siner, Robert A. French, Ben J. Lee, Valder R. Arruda, Mary Beth Callan

Get full text

Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog by Lucas Van Gorder, Bhavya S. Doshi, Elinor Willis, Timothy C. Nichols, Emma Cook, John K. Everett, Elizabeth P. Merricks, Valder R. Arruda, Frederic D. Bushman, Mary Beth Callan, Benjamin J. Samelson-Jones

Get full text